by M Dilley Cited by 41The most common type of hypersensitivity reaction to clindamycin is a delayed maculopapular rash usually 7–10 days after initiation of the drug
The most common type of hypersensitivity reaction to clindamycin is a delayed maculopapular rash usually 7 10 days after initiation of the drug [1, 32]. Various case reports describe maculopapular skin eruptions with clindamycin [33 36]. Studies in the 2024s reported an incidence of rashes with clindamycin in approximately 10% of patients .
The most common type of hypersensitivity reaction to clindamycin is a delayed maculopapular rash usually 7 10 days after initiation of the drug [1, 32]. Various case reports describe maculopapular skin eruptions with clindamycin [33 36]. Studies in the 2024s reported an incidence of rashes with clindamycin in approximately 10% of patients .
by M Dilley 2024 Cited by 41The most common type of hypersensitivity reaction to clindamycin is a delayed maculopapular rash usually 7–10 days after initiation of the drug
The most common type of hypersensitivity reaction to clindamycin is a delayed maculopapular rash usually 7 10 days after initiation of the drug [1, 32]. Various case reports describe maculopapular skin eruptions with clindamycin [33 36]. Studies in the 2024s reported an incidence of rashes with clindamycin in approximately 10% of patients .
by M Dilley 2024 Cited by 40The most common type of hypersensitivity reaction to clindamycin is a delayed maculopapular rash usually 7–10 days after initiation of the drug
Delayed hypersensitivity reaction: Maculopapular rash: Intermediate; usually 7 to 10 days after initiation (Ref). clindamycin: Infants 30 days of age.
by M Dilley 2024 Cited by 41The most common type of hypersensitivity reaction to clindamycin is a delayed maculopapular rash usually 7–10 days after initiation of the drug
The most common type of hypersensitivity reaction to clindamycin is a delayed maculopapular rash usually 7 10 days after initiation of the drug [1, 32]. Various case reports describe maculopapular skin eruptions with clindamycin [33 36]. Studies in the 2024s reported an incidence of rashes with clindamycin in approximately 10% of patients .
Comments